K. D. Tjandraprawira, R. Panigoro, Y. M. Hidayat, H. Susanto, and E. Sahiratmadja, “Epidermal growth factor polymorphism most prevalent in stage II cervical carcinoma”, Univ Med, vol. 33, no. 3, pp. 192–198, Dec. 2014.